熱門資訊> 正文

Gain Therapeutics宣布推出价值1亿美元的混合货架产品

2025-05-29 05:16

Gain Therapeutics, Inc.(GANX) 0

Gain Therapeutics (NASDAQ:GANX) has filed a shelf registration to offer up to $100M in various securities.
The potential offerings may include common stock, preferred stock, warrants, debt securities, subscription rights, or units.
GANX shares rise nearly 3% post-market on Wednesday.
Source: SEC filing

More on Gain Therapeutics

Seeking Alpha’s Quant Rating on Gain Therapeutics
Historical earnings data for Gain Therapeutics
Financial information for Gain Therapeutics

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。